Biofourmis procures $100m Series C
Biofourmis, a provider of digital therapeutics that powers personalized predictive care, has closed $100 million in Series C financing.
Biofourmis, a provider of digital therapeutics that powers personalized predictive care, has closed $100 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination
